LiST: Lives Saved Tool

BMCSalam, R.A., et al., Emollient therapy for preterm newborn infants--evidence from the developing world. BMC Public Health, 2013. 13 Suppl 3: p. S31.

Introduction

Application of emollients is a widespread traditional newborn care practice in many low and middle-income countries (LMICs) and may have the potential to decrease infection and consequent mortality in preterm neonates.

Methods

We systematically reviewed literature published up to December 2012 to identify studies describing the effectiveness of emollient therapy. We used a standardized abstraction and grading format to estimate the effect of emollient therapy by applying the standard Child Health Epidemiology Reference Group (CHERG) rules.

Results

We included seven studies and one unpublished trial in this review. Topical emollient therapy significantly reduced neonatal mortality by 27% (RR: 0.73, 95% CI: 0.56, 0.94) and hospital acquired infection by 50% (RR: 0.50, 95% CI: 0.36, 0.71). There were significant increases in weight (g) (MD: 98.04, 95% CI: 42.64, 153.45) and weight gain (g/kg/day) (MD: 1.57, 95% CI: 0.79, 2.36), whereas the impacts were non-significant for length and head circumference.

Conclusion

Emollient therapy is associated with improved weight gain, reduced risk of infection and associated newborn mortality in preterm neonates and is a potentially promising intervention for use in low resource settings. Large scale effectiveness trials are required to further assess the impact of this intervention.

Go to Article

Featured News

Findings from Lives Saved Tool (LiST) presented in Save The Children’s newest report

 November 6, 2017 – Save the Children recently released their report, Fighting for Breath, which urges stakeholders to focus on the prevention and treatment of childhood pneumonia worldwide.

Read more ...
Go to top